Sponsor

Centre Hospitalier Universitaire De Dijon

France 1 Boulevard Jeanne D Arc, Bp 77908, 21000 Dijon, France

About the sponsor

Clinical research includes colorectal cancer, rectal cancer, small bowel adenocarcinoma, and ampullary adenocarcinoma, with interest in neoadjuvant and adjuvant chemotherapy, ctDNA-guided treatment, and surgery-related cancer care. Studies also extend to advanced gastroenteropancreatic neuroendocrine carcinoma.

Colorectal cancer
Rectal cancer
Small bowel adenocarcinoma
Ampullary adenocarcinoma

The sponsor is active in perioperative and post-surgical oncology, including strategies linked to microsatellite instability and mismatch repair deficiency.

About Specializations

Centre Hospitalier Universitaire De Dijon runs clinical trials in conditions such as Vasoplegia syndrome, Colon cancer, Small intestine adenocarcinoma, Giant cell arteritis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

21 clinical trials

Vasoplegia syndrome

Recruiting

Early Treatment with Argipressin (Arginine Vasopressin) in Adult Intensive Care Patients with Norepinephrine-Resistant Vasoplegic Shock

Registered drug

Early Treatment with Argipressin (Arginine Vasopressin) in Adult Intensive Care Patients with Norepinephrine-Resistant Vasoplegic Shock

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Argipressin
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Cognitive disorder

Recruiting

Study on Lithium Carbonate for Patients with TBR1-Related Neurocognitive Disorder

Registered drugNo placebo

Study on Lithium Carbonate for Patients with TBR1-Related Neurocognitive Disorder

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lithium Carbonate
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Rectal cancer+2

Recruiting

Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

Registered drugNo placebo

Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dostarlimab
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Colon cancer

Recruiting

Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

Registered drugNo placebo

Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Neurogenic bladder

Recruiting

Study on E. coli Polysaccharide for Reducing Antibiotic Use in Patients with Neurogenic Bladder and Recurrent Urinary Tract Infections

Registered drug

Study on E. coli Polysaccharide for Reducing Antibiotic Use in Patients with Neurogenic Bladder and Recurrent Urinary Tract Infections

Registered drug

France

Participants:18–64 years · 65+ years
Substances:E.coli Polysaccharide
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Tumour of ampulla of Vater

Recruiting

Study Comparing mFOLFIRINOX and Capecitabine or Gemcitabine for Patients with Resected Ampullary Adenocarcinoma

Registered drugNo placebo

Study Comparing mFOLFIRINOX and Capecitabine or Gemcitabine for Patients with Resected Ampullary Adenocarcinoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Diabetic retinal oedema

Recruiting

Study Comparing Fluocinolone Acetonide and Dexamethasone Implants for Patients with Resistant Diabetic Macular Edema

Registered drugNo placebo

Study Comparing Fluocinolone Acetonide and Dexamethasone Implants for Patients with Resistant Diabetic Macular Edema

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dexamethasone
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Diabetes mellitus

Recruiting

Study on the Effect of Semaglutide in Patients with Type 1 Diabetes and Insulin Resistance

Registered drugNo placebo

Study on the Effect of Semaglutide in Patients with Type 1 Diabetes and Insulin Resistance

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Autoimmune haemolytic anaemia

Recruiting

Study on the Effectiveness of Apixaban and Enoxaparin Sodium in Preventing Blood Clots in Patients with Autoimmune Hemolytic Anemia

Registered drugNo placebo

Study on the Effectiveness of Apixaban and Enoxaparin Sodium in Preventing Blood Clots in Patients with Autoimmune Hemolytic Anemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Colon cancer

Recruiting

Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

Registered drugNo placebo

Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Small intestine adenocarcinoma

Recruiting

Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

Registered drugNo placebo